glp-1 fda approval approved indications for glp 1 An estimated 148 million US adults meet FDA-approved at FDA Approves First Oral GLP-1

Zhang et al., 2020

This glucose-dependent action is part of why it carries a lower risk of causing dangerously low blood sugar compared with some older diabetes medications

Modulating melanin production: It may influence melanin synthesis by shifting production toward lighter pigments, gradually supporting a brighter and more even skin tone (NIH)

A study compared oral, sublingual, and intramuscular B12

Raun, K., et al

In the pig LR3 IGF-1 study, plasma endogenous IGF-1 was suppressed during infusion (Tomas et al., 1997), and the guinea pig study showed reduced plasma IGF-I and IGF-II during LR3 administration (Bastian et al., 1995)